With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Identifying Drug Resistant Mutations in Ph-like Acute Lymphoblastic Leukemia||University of California San Francisco / Mignon Loh, M.D.||Innovation Grants||2014||California|
|Space-Time Analysis of the California Birth Cohort: 30 Years of Childhood Cancer||University of California Berkeley / Steve Selvin, PhD||Epidemiology Grants||2015||California|
|Targeting inhibitory phosphatase signaling in high-risk childhood ALL||University of California San Francisco / Markus Muschen, MD, PhD||Innovation Grants||2011||California|
|Harmonizing Data Sharing Efforts towards a Federated Data Model||University of California at Santa Cruz / Olena M. Vaske, PhD & David Haussler, PhD||Crazy 8 Pilots||2019||California|
|Targeting eEF2 Kinase in Neuroblastoma||University of California San Francisco / William Weiss, M.D., Ph.D.||Innovation Grants||2014||California|
|Studying the clonal dynamics and evolution of leukemia using molecular barcodes||Lucile Packard Children's Hospital at Stanford University School of Medicine / Matthew Porteus, MD, PhD||Innovation Grants||2011||California|
|Identifying novel biomarkers for risk stratification in t-cell acute lymphoblastic leukemia (ALL).||University of California San Francisco / Michelle Hermiston, MD, PhD||Young Investigator Grants||2009||California|
|The role of OCT4 in self-renewal signaling and drug-resistance of childhood acute lymphoblastic leukemia||Children's Hospital Los Angeles / Markus Muschen||Innovation Grants||2008||California|
|STING Pathway Activation: The Missing Link between Genomic Instability and Antitumor Immunity in Osteosarcoma||University of California San Francisco / Elizabeth Young, MD||Young Investigator Grants||2021||California|
|Expanding Innovative Pediatric Cancer Clinical Trial Access at Stanford||Stanford University / Maria-Grazia Roncarolo, M.D. & Sherri Spunt, M.D.||Phase I/II Infrastructure Grants||2015||California|